Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Jun;49(6):391–395. doi: 10.1136/ard.49.6.391

Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.

D J de Rooij 1, W J Habets 1, L B van de Putte 1, M H Hoet 1, A L Verbeek 1, W J van Venrooij 1
PMCID: PMC1004107  PMID: 2383062

Abstract

In a three year prospective study disease activity variables and levels of antibody against the RNP-peptides 70K and A were measured in 18 patients with mixed connective tissue disease. Antibody measurement entailed use of cloned autoantigens in an enzyme linked immunosorbent assay (ELISA). Fluctuations in antibody levels against 70K and A were most commonly noted in patients who also had changes in disease activity, but these changes in serology and disease activity were synchronous in only a minority of the episodes. Even major disease flares were associated with changes in anti-A levels in only a few, and with changes in anti-70K levels in none of the episodes. The data indicate that measurements of anti-70K and anti-A levels are not useful in monitoring disease activity or response to treatment in mixed connective tissue disease, and suggest that these antibody specificities do not play a direct part in the pathogenesis of disease manifestations.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barada F. A., Jr, Andrews B. S., Davis J. S., 4th, Taylor R. P. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum. 1981 Oct;24(10):1236–1244. doi: 10.1002/art.1780241003. [DOI] [PubMed] [Google Scholar]
  2. Becker T. M., Lizzio E. F., Merchant B., Reeves J. P., Steinberg A. D. Increased multiclonal antibody-forming cell activity in the peripheral blood of patients with SLE. Int Arch Allergy Appl Immunol. 1981;66(3):293–303. doi: 10.1159/000232833. [DOI] [PubMed] [Google Scholar]
  3. Grant K. D., Adams L. E., Hess E. V. Mixed connective tissue disease - a subset with sequential clinical and laboratory features. J Rheumatol. 1981 Jul-Aug;8(4):587–598. [PubMed] [Google Scholar]
  4. Habets W. J., Berden J. H., Hoch S. O., Van Venrooij W. J. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol. 1985 Oct;15(10):992–997. doi: 10.1002/eji.1830151006. [DOI] [PubMed] [Google Scholar]
  5. Habets W. J., Hoet M. H., Sillekens P. T., De Rooij D. J., Van de Putte L. B., Van Venrooij W. J. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens. Clin Exp Immunol. 1989 May;76(2):172–177. [PMC free article] [PubMed] [Google Scholar]
  6. Habets W. J., de Rooij D. J., Hoet M. H., van de Putte L. B., van Venrooij W. J. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol. 1985 Feb;59(2):457–466. [PMC free article] [PubMed] [Google Scholar]
  7. Habets W. J., de Rooij D. J., Salden M. H., Verhagen A. P., van Eekelen C. A., van de Putte L. B., van Venrooij W. J. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol. 1983 Oct;54(1):265–276. [PMC free article] [PubMed] [Google Scholar]
  8. Houtman P. M., Kallenberg C. G., Limburg P. C., Huitema M. G., van Rijswijk M. H., The T. H. Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease. Clin Exp Immunol. 1985 Dec;62(3):696–704. [PMC free article] [PubMed] [Google Scholar]
  9. Houtman P. M., Kallenberg C. G., Limburg P. C., van Leeuwen M. A., van Rijswijk M. H., The T. H. Fluctuations in anti-nRNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response. Ann Rheum Dis. 1986 Oct;45(10):800–808. doi: 10.1136/ard.45.10.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lightfoot R. W., Jr, Hughes G. R. Significance of persisting serologic abnormalities in SLE. Arthritis Rheum. 1976 Sep-Oct;19(5):837–843. doi: 10.1002/art.1780190501. [DOI] [PubMed] [Google Scholar]
  11. McCain G. A., Bell D. A., Chodirker W. B., Komar R. R. Antibody to extractable nuclear antigen in the rheumatic diseases. J Rheumatol. 1978 Winter;5(4):399–406. [PubMed] [Google Scholar]
  12. Miniter M. F., Stollar B. D., Agnello V. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum. 1979 Sep;22(9):959–968. doi: 10.1002/art.1780220903. [DOI] [PubMed] [Google Scholar]
  13. Netter H. J., Guldner H. H., Szostecki C., Lakomek H. J., Will H. A recombinant autoantigen derived from the human (U1) small nuclear RNP-specific 68-kd protein. Expression in Escherichia coli and serodiagnostic application. Arthritis Rheum. 1988 May;31(5):616–622. doi: 10.1002/art.1780310506. [DOI] [PubMed] [Google Scholar]
  14. Nishikai M., Okano Y., Mukohda Y., Sato A., Ito M. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis. J Clin Lab Immunol. 1984 Jan;13(1):15–19. [PubMed] [Google Scholar]
  15. Pettersson I., Hinterberger M., Mimori T., Gottlieb E., Steitz J. A. The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem. 1984 May 10;259(9):5907–5914. [PubMed] [Google Scholar]
  16. Pettersson I., Wang G., Smith E. I., Wigzell H., Hedfors E., Horn J., Sharp G. C. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum. 1986 Aug;29(8):986–996. doi: 10.1002/art.1780290807. [DOI] [PubMed] [Google Scholar]
  17. Rothfield N., Whitaker D., Bordwell B., Weiner E., Senecal J. L., Earnshaw W. Detection of anticentromere antibodies using cloned autoantigen CENP-B. Arthritis Rheum. 1987 Dec;30(12):1416–1419. doi: 10.1002/art.1780301214. [DOI] [PubMed] [Google Scholar]
  18. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  19. Scopelitis E., Biundo J. J., Jr, Alspaugh M. A. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum. 1980 Mar;23(3):287–293. doi: 10.1002/art.1780230304. [DOI] [PubMed] [Google Scholar]
  20. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 Feb;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2. [DOI] [PubMed] [Google Scholar]
  21. Sillekens P. T., Habets W. J., Beijer R. P., van Venrooij W. J. cDNA cloning of the human U1 snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific proteins. EMBO J. 1987 Dec 1;6(12):3841–3848. doi: 10.1002/j.1460-2075.1987.tb02721.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sullivan W. D., Hurst D. J., Harmon C. E., Esther J. H., Agia G. A., Maltby J. D., Lillard S. B., Held C. N., Wolfe J. F., Sunderrajan E. V. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984 Mar;63(2):92–107. doi: 10.1097/00005792-198403000-00003. [DOI] [PubMed] [Google Scholar]
  23. Swaak A. J., Groenwold J., Aarden L. A., Statius van Eps L. W., Feltkamp E. W. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis. 1982 Aug;41(4):388–395. doi: 10.1136/ard.41.4.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Swaak A. J., Groenwold J., Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis. 1986 May;45(5):359–366. doi: 10.1136/ard.45.5.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  26. Venables P. J., Charles P. J., Buchanan R. R., Yi T., Mumford P. A., Schrieber L., Room G. R., Maini R. N. Quantitation and detection of isotypes of anti-SS-B antibodies by ELISA and Farr assays using affinity purified antigens. An approach to the investigation of Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum. 1983 Feb;26(2):146–155. doi: 10.1002/art.1780260205. [DOI] [PubMed] [Google Scholar]
  27. Whittingham S., Naselli G., McNeilage L. J., Coppel R. L., Sturgess A. D. Serological diagnosis of primary Sjögren's syndrome by means of human recombinant La (SS-B) as nuclear antigen. Lancet. 1987 Jul 4;2(8549):1–3. [PubMed] [Google Scholar]
  28. de Rooij D. J., van de Putte L. B., Habets W. J., Verbeek A. L., van Venrooij W. J. The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases. Scand J Rheumatol. 1988;17(5):353–364. doi: 10.3109/03009748809105271. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES